ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1568
0,37%
Bitcoin
60.984,54
0,30%
Brent Oil
82,585
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. XORTX Therapeutics Inc (XRTX)

  7. XORTX Therapeutics Inc (XRTX) Notícias

XRTX

XORTX Therapeutics (XRTX)

XORTX Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:XRTX
DataHoraFonteTítuloCódigoCompanhia
10/05/202417:10Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:XRTXXORTX Therapeutics Inc
30/04/202414:54GlobeNewswire Inc.XORTX Reprices Warrants Issued in Connection with Previous Private PlacementsNASDAQ:XRTXXORTX Therapeutics Inc
22/04/202408:00GlobeNewswire Inc.XORTX Announces Publication of Key Research in ADPKDNASDAQ:XRTXXORTX Therapeutics Inc
08/04/202408:30GlobeNewswire Inc.XORTX Welcomes New Member to the Board of DirectorsNASDAQ:XRTXXORTX Therapeutics Inc
08/04/202408:00GlobeNewswire Inc.XORTX Announces Participation in Spring 2024 Investor ConferencesNASDAQ:XRTXXORTX Therapeutics Inc
27/03/202406:00GlobeNewswire Inc.XORTX Announces New Clinical Advisory Board MemberNASDAQ:XRTXXORTX Therapeutics Inc
19/03/202406:00GlobeNewswire Inc.XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical TrialNASDAQ:XRTXXORTX Therapeutics Inc
04/03/202409:00GlobeNewswire Inc.XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
15/02/202409:00GlobeNewswire Inc.XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
01/02/202422:46GlobeNewswire Inc.XORTX Files an Amended and Restated Prospectus Supplement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
15/01/202409:00GlobeNewswire Inc.XORTX Announces $2 Million Public OfferingNASDAQ:XRTXXORTX Therapeutics Inc
03/01/202409:25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
03/01/202409:00GlobeNewswire Inc.XORTX Submits a New Patent for the Treatment of Chronic Kidney DiseaseNASDAQ:XRTXXORTX Therapeutics Inc
30/11/202309:30GlobeNewswire Inc.XORTX Announces US ATM OfferingNASDAQ:XRTXXORTX Therapeutics Inc
29/11/202323:57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XRTXXORTX Therapeutics Inc
29/11/202309:00GlobeNewswire Inc.XORTX Meets Nasdaq Continued Listing RequirementsNASDAQ:XRTXXORTX Therapeutics Inc
10/11/202309:00GlobeNewswire Inc.XORTX Clarifies Timing for Share ConsolidationNASDAQ:XRTXXORTX Therapeutics Inc
08/11/202319:00GlobeNewswire Inc.XORTX Announces Share ConsolidationNASDAQ:XRTXXORTX Therapeutics Inc
02/11/202308:00GlobeNewswire Inc.XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023NASDAQ:XRTXXORTX Therapeutics Inc
27/10/202318:30GlobeNewswire Inc.XORTX Announces Results of Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
25/10/202318:00GlobeNewswire Inc.XORTX Announces Date for Rescheduled Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
25/10/202308:00GlobeNewswire Inc.XORTX Announces Rescheduling of Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
12/10/202308:00GlobeNewswire Inc.XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation ResolutionNASDAQ:XRTXXORTX Therapeutics Inc
04/10/202308:00GlobeNewswire Inc.XORTX Calls Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
28/09/202308:00GlobeNewswire Inc.XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023NASDAQ:XRTXXORTX Therapeutics Inc
11/09/202308:00GlobeNewswire Inc.XORTX Announces Participation at Upcoming Investor ConferencesNASDAQ:XRTXXORTX Therapeutics Inc
07/09/202308:00GlobeNewswire Inc.XORTX Joins the Kidney Foundation and Kidney MarchNASDAQ:XRTXXORTX Therapeutics Inc
29/08/202308:00GlobeNewswire Inc.XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney DiseaseNASDAQ:XRTXXORTX Therapeutics Inc
25/08/202307:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
08/08/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XRTXXORTX Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:XRTX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BHIA3
Grupo Casas Bahia ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PETZ3
Pet Center Comercio E Pa... ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
GUAR3
GUARARAPES ON
BOV
TELB4
TELEBRAS PN
BOV
LREN3
LOJAS RENNER ON
BOV
IDIV
Dividend
BOV
PETR4
PETROBRAS PN
BOV
GOLL4
GOL PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados